Financial reports
10-Q
2021 Q3
Quarterly report
5 Nov 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
10-Q
2021 Q1
Quarterly report
30 Apr 21
10-K/A
2020 FY
Annual report (amended)
29 Apr 21
10-K
2020 FY
Annual report
26 Feb 21
10-Q
2020 Q3
Quarterly report
29 Oct 20
10-Q
2020 Q2
Quarterly report
29 Jul 20
10-Q
2020 Q1
Quarterly report
11 May 20
10-K
2019 FY
Annual report
28 Feb 20
10-Q
2019 Q3
Quarterly report
1 Nov 19
Current reports
8-K
Termination of a Material Definitive Agreement
4 Jan 22
8-K
Centene and Magellan Satisfy All Regulatory Approvals
30 Dec 21
8-K
Magellan Health Reports Third Quarter 2021 Financial Results
5 Nov 21
8-K
Magellan Health Reports Second Quarter 2021 Financial Results
5 Aug 21
8-K
Magellan Health Reports First Quarter 2021 Financial Results
30 Apr 21
8-K
Submission of Matters to a Vote of Security Holders
31 Mar 21
8-K
Other Events
19 Mar 21
8-K
Magellan Health Reports 2020 Financial Results
26 Feb 21
8-K/A
Financial Statements and Exhibits
6 Jan 21
8-K
Ken Fasola’s Employee Announcement Email
4 Jan 21
Registration and prospectus
15-12B
Securities registration termination
14 Jan 22
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Jan 22
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Jan 22
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Jan 22
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Jan 22
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Jan 22
25-NSE
Exchange delisting
4 Jan 22
S-8
Registration of securities for employees
12 Jun 18
424B2
Prospectus for primary offering
18 Sep 17
424B2
Prospectus for primary offering
15 Sep 17
Proxies
DEFA14A
Additional proxy soliciting materials
19 Mar 21
DEFM14A
Proxy related to merger
19 Feb 21
PREM14A
Preliminary proxy related to merger
8 Feb 21
DEFA14A
Additional proxy soliciting materials
5 Jan 21
DFAN14A
Additional proxy materials by non-management
4 Jan 21
DEFA14A
Additional proxy soliciting materials
4 Jan 21
DEFA14A
Additional proxy soliciting materials
4 Jan 21
DEFA14A
Additional proxy soliciting materials
4 Jan 21
DEFA14A
Additional proxy soliciting materials
2 Jun 20
DEF 14A
Definitive proxy
29 Apr 20
Other
UPLOAD
Letter from SEC
30 May 17
CORRESP
Correspondence with SEC
19 May 17
UPLOAD
Letter from SEC
10 May 17
UPLOAD
Letter from SEC
1 Sep 16
CORRESP
Correspondence with SEC
29 Aug 16
CT ORDER
Confidential treatment order
23 Aug 16
UPLOAD
Letter from SEC
2 Aug 16
UPLOAD
Letter from SEC
10 Sep 15
CORRESP
Correspondence with SEC
11 Aug 15
UPLOAD
Letter from SEC
31 Jul 15
Ownership
SC 13G/A
Evolent Health, Inc.
26 Apr 23
SC 13G/A
UBS OCONNOR LLC
13 Feb 23
SC 13G
Evolent Health, Inc.
27 Jan 23
SC 13G
UBS OCONNOR LLC
14 Feb 22
SC 13G/A
VANGUARD GROUP INC
10 Feb 22
SC 13G/A
DIMENSIONAL FUND ADVISORS LP
8 Feb 22
SC 13G/A
VICTORY CAPITAL MANAGEMENT INC
2 Feb 22
SC 13G/A
BlackRock Inc.
27 Jan 22
SC 13G
BlackRock Inc.
25 Jan 22
SC 13D/A
Starboard Value LP
6 Jan 22